XML 25 R10.htm IDEA: XBRL DOCUMENT
v3.24.4

Note 2 - Marketable Securities and Investment Other Securities | 12 Months Ended
--- | ---
Sep. 30, 2024
Notes to Financial Statements |
Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block] | NOTE 2 – MARKETABLE SECURITIES AND INVESTMENT OTHER SECURITIES On April 7, 2022, the Company entered into an asset sale agreement to sell substantially all its manufacturing assets to a subsidiary of Steady State, LLC ("Steady State"). The equipment sale was initially valued at approximately $1.8 million for accounting purposes, the sale price consisting of a trade credit for products to be provided to the Company under the manufacturing and supply agreement and $1.4 million of which the Company invested into Steady State in the form of an equity investment consistent with the terms of Steady State's completed Series C financing. The Company performed a valuation analysis and as of September 30, 2023 determined a $700,000 impairment was needed on the carrying value of this investment. The determination was based on a number of factors, including Steady State’s financial performance, our experience with production and cbdMD’s determination to re-source production to other suppliers. As such we believe it was prudent to reassess the carrying value of this non-liquid security. The Company performed an additional valuation analysis as of September 30, 2024 and determined that no further impairment was needed based on factors such as Steady State's financial performance and re-alignment of the business. For the year ended September 30, 2024 and September 30, 2023 the Company recorded $0 and an unrealized loss of $700,000, respectively of realized and unrealized loss on marketable and other securities, including impairments. The table below summarizes the assets and liabilities related to marketable and other securities valued at fair value as of September 30, 2024:
|  | In Active |  |  |  |  |  |  |  |  |
|  | Markets for |  |  | Significant Other |  |  | Significant |
|  | Identical Assets |  |  | Observable |  |  | Unobservable |
|  | and Liabilities |  |  | Inputs |  |  | Inputs |
|  | (Level 1) |  |  | (Level 2) |  |  | (Level 3) |
Balance at September 30, 2022 |  | $ | - |  |  | $ | - |  |  | $ | (276,000 | )
Change in value of equities |  |  | - |  |  |  | - |  |  |  | - |
Change in value of contingent liability |  |  | - |  |  |  | - |  |  |  | - |
Additional Investment |  |  | - |  |  |  | - |  |  |  | 185,638 |
Balance at September 30, 2023 |  |  | - |  |  |  | - |  |  |  | (90,362 | )
Change in value of contingent liability |  |  | - |  |  |  | - |  |  |  | 90,362 |
Fair value of convertible notes |  |  |  |  |  |  |  |  |  |  | 1,171,308 |
Balance at September 30, 2024 |  | $ | - |  |  | $ | - |  |  | $ | 1,171,308 |

X
- References No definition available. + Details
Name: | us-gaap_DisclosureTextBlockAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for investments in certain debt and equity securities. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 940 -SubTopic 320 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/940-320/tableOfContent Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name Regulation S-K (SK) -Number 229 -Section 1403 -Paragraph b -Publisher SEC Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 320 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/320/tableOfContent Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 320 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 10 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481800/320-10-50-10 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6B -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6B Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6B -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6B Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 942 -SubTopic 320 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/942-320/tableOfContent + Details
Name: | us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration